U.S. flag

An official website of the United States government

NM_000102.4(CYP17A1):c.1247G>A (p.Arg416His) AND Deficiency of steroid 17-alpha-monooxygenase

Germline classification:
Pathogenic/Likely pathogenic (2 submissions)
Last evaluated:
Mar 25, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003225015.3

Allele description [Variation Report for NM_000102.4(CYP17A1):c.1247G>A (p.Arg416His)]

NM_000102.4(CYP17A1):c.1247G>A (p.Arg416His)

Gene:
CYP17A1:cytochrome P450 family 17 subfamily A member 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q24.32
Genomic location:
Preferred name:
NM_000102.4(CYP17A1):c.1247G>A (p.Arg416His)
HGVS:
  • NC_000010.11:g.102830982C>T
  • NG_007955.1:g.11552G>A
  • NM_000102.4:c.1247G>AMANE SELECT
  • NP_000093.1:p.Arg416His
  • NC_000010.10:g.104590739C>T
  • NM_000102.3:c.1247G>A
Protein change:
R416H; ARG416HIS
Links:
OMIM: 609300.0031; dbSNP: rs104894155
NCBI 1000 Genomes Browser:
rs104894155
Molecular consequence:
  • NM_000102.4:c.1247G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Deficiency of steroid 17-alpha-monooxygenase
Synonyms:
ADRENAL HYPERPLASIA V; 17-alpha-hydroxylase deficiency; Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0008730; MedGen: C0268285; OMIM: 202110

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003921116Lifecell International Pvt. Ltd
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenicgermlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

SCV004215416Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Mar 25, 2024)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing
Asiangermlineyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

Two novel mutations found in a patient with 17alpha-hydroxylase enzyme deficiency.

Ergun-Longmire B, Auchus R, Papari-Zareei M, Tansil S, Wilson RC, New MI.

J Clin Endocrinol Metab. 2006 Oct;91(10):4179-82. Epub 2006 Jul 18.

PubMed [citation]
PMID:
16849412

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Lifecell International Pvt. Ltd, SCV003921116.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1Asian1not providednot providedclinical testing PubMed (2)

Description

A Homozygote Missense variant c.1247G>A in Exon 8 of the CYP17A1 gene that results in the amino acid substitution p.Arg416His was identified. The observed variant has a minor allele frequency of 0.00003% in gnomAD genomes. The severity of the impact of this variant on the protein is medium, based on the effect of the protein and REVEL score . Rare Exome Variant Ensemble Learner (REVEL) is an ensembl method for predicting the pathogenicity of missense variants based on a combination of scores from 13 individual tools: MutPred, FATHMM v2.3, VEST 3.0, PolyPhen-2, SIFT, PROVEAN, MutationAssessor, MutationTaster, LRT, GERP++, SiPhy, phyloP, and phastCons. The REVEL score for an individual missense variant can range from 0 to 1, with higher scores reflecting greater likelihood that the variant is disease-causing. ClinVar has also classified this variant as Likely Pathogenic (Variant ID-1804). This variant has been previously reported in Ergun-Longmire B et al., 2006. Expression studies revealed no detectable activity of the encoded protein (Ergun-Longmire B et al., 2006). Based on the above evidence this variant has been classified as Pathogenic according to the ACMG guidelines.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

From Baylor Genetics, SCV004215416.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024